GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Guangzhou Kingmed Diagnostics Group Co., Ltd. Stock
Equities
603882
CNE100002VW1
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.68 CNY | -2.15% |
|
-7.27% | -46.17% |
| Sales 2024 * | 9.63B 1.33B | Sales 2025 * | 11.34B 1.57B | Capitalization | 15.65B 2.16B |
|---|---|---|---|---|---|
| Net income 2024 * | 822M 114M | Net income 2025 * | 1.2B 166M | EV / Sales 2024 * | 1.11 x |
| Net cash position 2024 * | 4.93B 680M | Net cash position 2025 * | 5.64B 779M | EV / Sales 2025 * | 0.88 x |
| P/E ratio 2024 * |
16.4
x | P/E ratio 2025 * |
12.5
x | Employees | 11,586 |
| Yield 2024 * |
3.26% | Yield 2025 * |
3.69% | Free-Float | 58.09% |
More Fundamentals
* Assessed data
More news
More recommendations
| 1 day | -2.15% | ||
| 1 week | -7.27% | ||
| 1 month | -12.18% | ||
| 3 months | -44.15% | ||
| 6 months | -48.97% | ||
| Current year | -46.17% |
1 week
33.68
36.59
1 month
33.6841.36
Current year
33.6866.87
1 year
33.6878.60
3 years
33.68160.19
5 years
29.20178.88
10 years
9.98178.88
| Managers | Title | Age | Since |
|---|---|---|---|
Yao Ming Liang
CEO | Chief Executive Officer | 60 | 05-12-31 |
Bi Xi Hao
DFI | Director of Finance/CFO | 54 | 10-12-31 |
Xiao Feng Zou
BRD | Director/Board Member | 44 | 20-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yao Ming Liang
CEO | Chief Executive Officer | 60 | 05-12-31 |
Ting Yan
BRD | Director/Board Member | 55 | 05-12-31 |
Zhan Wen Zeng
BRD | Director/Board Member | 58 | 05-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.63% | 2 M€ | -18.79% | - | |
| 0.41% | 2 M€ | -14.14% | ||
| 0.37% | 12 M€ | -16.71% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 33.68 | -2.15% | 7,611,535 |
| 24-05-30 | 34.42 | -0.95% | 4,990,759 |
| 24-05-29 | 34.75 | +0.29% | 5,600,159 |
| 24-05-28 | 34.65 | -3.10% | 10,558,090 |
| 24-05-27 | 35.76 | -1.54% | 5,510,142 |
End-of-day quote Shanghai S.E., May 30, 2024
More quotes
Guangzhou Kingmed Diagnostics Group Co Ltd is a company that mainly provides medical diagnosis services. The Company is also engaged in other businesses, including sales of diagnostic products, provision of physical examination and cold chain logistics services.
Calendar
2024-08-13
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
33.68
CNY
Average target price
61.61
CNY
Spread / Average Target
+82.93%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -46.17% | 2.16B | |
| -24.16% | 7.76B | |
| +68.65% | 4.33B | |
| -2.98% | 2.64B | |
| +2.72% | 2.63B | |
| -22.12% | 1.46B | |
| +13.62% | 1.17B | |
| -43.81% | 1.14B | |
| +20.41% | 999M | |
| -9.27% | 955M |
- Stock Market
- Equities
- 603882 Stock
